NSUN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.349600E-01
Normal-vs-Stage2
7.673600E-01
Normal-vs-Stage3
7.116400E-01
Normal-vs-Stage4
6.348200E-01
Stage1-vs-Stage2
8.539600E-01
Stage1-vs-Stage3
7.511200E-01
Stage1-vs-Stage4
6.989800E-01
Stage2-vs-Stage3
7.362200E-01
Stage2-vs-Stage4
6.161000E-01
Stage3-vs-Stage4
9.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.500800E-01
Normal-vs-AfricanAmerican
9.088000E-01
Normal-vs-Asian
9.952000E-01
Caucasian-vs-AfricanAmerican
9.558000E-01
Caucasian-vs-Asian
5.359400E-01
AfricanAmerican-vs-Asian
8.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.060200E-01
Normal-vs-Female
8.089800E-01
Male-vs-Female
7.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.029800E-01
Normal-vs-Age(41-60Yrs)
8.805000E-01
Normal-vs-Age(61-80Yrs)
7.064200E-01
Normal-vs-Age(81-100Yrs)
8.591200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.911800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.799600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.365600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.572400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.077000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.106400E-01
Normal-vs-Daily Drinker
9.561600E-01
Normal-vs-Weekly Drinker
7.652200E-01
Normal-vs-Occasional Drinker
7.883800E-01
Normal-vs-Social Drinker
8.626800E-01
Non Drinker-vs-Daily Drinker
2.284400E-01
Non Drinker-vs-Weekly Drinker
1.131630E-01
Non Drinker-vs-Occasional Drinker
9.266200E-02
Non Drinker-vs-Social Drinker
6.040800E-01
Daily Drinker-vs-Weekly Drinker
5.895000E-01
Daily Drinker-vs-Occasional Drinker
7.185200E-01
Daily Drinker-vs-Social Drinker
4.632200E-01
Weekly Drinker-vs-Occasional Drinker
7.877400E-01
Weekly Drinker-vs-Social Drinker
2.803400E-01
Occasional Drinker-vs-Social Drinker
2.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.868000E-01
Normal-vs-Grade 2
9.152400E-01
Normal-vs-Grade 3
9.534200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.714000E-01
Grade 1-vs-Grade 3
2.350600E-01
Grade 1-vs-Grade 4
8.868000E-01
Grade 2-vs-Grade 3
2.975400E-01
Grade 2-vs-Grade 4
9.152400E-01
Grade 3-vs-Grade 4
9.534200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.722800E-01
Normal-vs-NonDiabetic
8.591000E-01
Diabetic-vs-NonDiabetic
1.582390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.936600E-01
Normal-vs-NoPancreatitis
7.370400E-01
Pancreatitis-vs-NoPancreatitis
1.991580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.510600E-01
Normal-vs-N1
7.411400E-01
N0-vs-N1
8.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.306600E-01
Normal-vs-TP53-NonMutant
6.949600E-01
TP53-Mutant-vs-TP53-NonMutant
4.752300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
